Related content

Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity

By Tomas M.   Sent M.   Elosua R.   Vila J.   Sala J.   Masia R.   Marrugat J.  

European Journal of Pharmacology, Vol. 432, Iss. 2, 2001-12 ,pp. : 121-128

Elsevier

Access to resources Recommend Favorite

Strategies for Modifying High-Density Lipoprotein Cholesterol: A Role for Nicotinic Acid

By Schachter Michael  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 6, 2005-12 ,pp. : 415-422

Springer Publishing Company

Access to resources Recommend Favorite

Human Serum Paraoxonase - inhibition of biological activity of minimally oxidized low density lipoprotein

By Mackness B.   Durrington P.N.   Mackness M.I.  

General Pharmacology, Vol. 31, Iss. 3, 1998-09 ,pp. : 329-336

Elsevier

Access to resources Recommend Favorite

Raising high-density lipoprotein cholesterol with inhibitors of cholesteryl ester transfer protein – a new approach to coronary artery disease

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1365-1368

Informa Healthcare

Access to resources Recommend Favorite

High-Density Lipoprotein-Mediated Anti-Atherosclerotic and Endothelial-Protective Effects: A Potential Novel Therapeutic Target in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 13, 2010-05 ,pp. : 1480-1493

Bentham Science Publishers

Access to resources Recommend Favorite